These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 29789601)

  • 1. HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.
    Fu F; Wang T; Wu Z; Feng Y; Wang W; Zhou S; Ma X; Wang S
    Cell Death Dis; 2018 May; 9(6):594. PubMed ID: 29789601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells.
    Sharma P; Yadav P; Jain RP; Bera AK; Karunagaran D
    Life Sci; 2022 Feb; 291():120268. PubMed ID: 34973275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells.
    Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
    Br J Cancer; 2016 Sep; 115(6):741-51. PubMed ID: 27537384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth arrest-specific 5 attenuates cisplatin-induced apoptosis in cervical cancer by regulating STAT3 signaling via miR-21.
    Yao T; Lu R; Zhang J; Fang X; Fan L; Huang C; Lin R; Lin Z
    J Cell Physiol; 2019 Jun; 234(6):9605-9615. PubMed ID: 30352127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21 promotes proliferation, migration, and invasion of cervical cancer through targeting TIMP3.
    Zhang Z; Wang J; Wang X; Song W; Shi Y; Zhang L
    Arch Gynecol Obstet; 2018 Feb; 297(2):433-442. PubMed ID: 29177591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.
    Xu J; Li Y; Wang F; Wang X; Cheng B; Ye F; Xie X; Zhou C; Lu W
    Oncogene; 2013 Feb; 32(8):976-87. PubMed ID: 22469983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
    Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
    Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpressed circ_0067934 acts as an oncogene to facilitate cervical cancer progression via the miR-545/EIF3C axis.
    Hu C; Wang Y; Li A; Zhang J; Xue F; Zhu L
    J Cell Physiol; 2019 Jun; 234(6):9225-9232. PubMed ID: 30362562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-196a targeting LRIG3 promotes the proliferation and migration of cervical cancer cells.
    Qiu Y; Han Q; Lu H; Shi C
    Cell Mol Biol (Noisy-le-grand); 2020 Oct; 66(7):180-185. PubMed ID: 33287939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
    Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
    Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-492 overexpression involves in cell proliferation, migration, and radiotherapy response of cervical squamous cell carcinomas.
    Liu M; An J; Huang M; Wang L; Tu B; Song Y; Ma K; Wang Y; Wang S; Zhu H; Xu N; Wu L
    Mol Carcinog; 2018 Jan; 57(1):32-43. PubMed ID: 28802022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H19 promotes the migration and invasion of colon cancer by sponging miR-138 to upregulate the expression of HMGA1.
    Yang Q; Wang X; Tang C; Chen X; He J
    Int J Oncol; 2017 May; 50(5):1801-1809. PubMed ID: 28358427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-195 reverses 5-FU resistance through targeting HMGA1 in gastric cancer cells.
    Wang CQ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3771-3778. PubMed ID: 31115003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
    Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
    Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-202 inhibits the progression of human cervical cancer through inhibition of cyclin D1.
    Yi Y; Li H; Lv Q; Wu K; Zhang W; Zhang J; Zhu D; Liu Q; Zhang W
    Oncotarget; 2016 Nov; 7(44):72067-72075. PubMed ID: 27732565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL.
    Wang Y; Dong X; Hu B; Wang XJ; Wang Q; Wang WL
    Biomed Pharmacother; 2016 May; 80():311-321. PubMed ID: 27133071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting dipeptidyl peptidase 8 genes inhibits proliferation, migration and invasion by inhibition of cyclin D1 and MMP2MMP9 signal pathway in cervical cancer.
    Chen Y; Liu F; Wu K; Wu W; Wu H; Zhang W
    J Gene Med; 2018 Dec; 20(12):e3056. PubMed ID: 30225951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
    Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW
    Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-106a promotes cell migration and invasion by targeting tissue inhibitor of matrix metalloproteinase 2 in cervical cancer.
    Li X; Zhou Q; Tao L; Yu C
    Oncol Rep; 2017 Sep; 38(3):1774-1782. PubMed ID: 28731196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.